More evidence this week of how unchecked drug price increases are forcing hospitals to make tough choices and are a serious economic threat to the patients and communities we serve. An AHA/Federation of American Hospitals-commissioned report by the University of Chicago’s NORC showed inpatient hospital drug costs increased more than 38% per admission between 2013 and 2015. An AHA infographic also outlined how rising drug prices are limiting patient access to needed medicines and are busting hospital budgets. What’s most surprising is that the list of worst offenders is dominated by old drugs, some of which have been on the market for decades. Their prices are being raised in seemingly random and unpredictable ways. When drug companies put profits before patients, we all pay the price. This is part of our overall strategy on drug pricing, which includes AHA’s membership in the Campaign for Sustainable Rx Pricing – a coalition of health care providers, insurers and seniors focused on highlighting the need for action and advocating for solutions to address the problem through greater transparency, competition and value. In fact, these ideas are consistent with our specific policy recommendations to rein in escalating drug prices, which were developed with input from member hospitals and health systems through our governance processRegardless of the outcome of the election, we will work with our coalition partners in a bipartisan manner to pursue legislation next year.  

Related News Articles

Headline
The House Energy and Commerce Committee today approved legislation to address surprise medical bills and Medicaid disproportionate share hospital cuts.
Headline
The Trump administration today withdrew a proposed rule that would eliminate the rebate safe harbor for pharmacy benefit managers under the federal anti-…
Headline
A federal judge yesterday struck down a Centers for Medicare…
Headline
Drug makers this week increased list prices for at least 104 different drugs, dosages or package sizes, with the average price increase 13.1%, according to an…
Headline
The Senate Judiciary Committee today passed four bills aimed at lowering prescription drug costs and increasing competition.
Headline
The Senate Committee on Health, Education, Labor and Pensions today voted 20-3 to pass the Lower Health Care Costs Act (S.1895) – bipartisan legislation…